Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Report Date: August 15, 2025
Reporting Period: The filing announces financial results for the three months and full fiscal year ended June 30, 2025. The company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The provided text serves as a cover report referencing a press release (Exhibit 99.1) containing the actual financial data. The filing text itself does not provide specific values for:
- Revenue
- Profit or Net Income
- Cash Flow
- Profit Margins
- Debt Levels
- Liquidity Positions
Note: Specific financial figures are not present in the 8-K cover text and must be sourced from the referenced Exhibit 99.1.
Material Changes
The filing text does not contain comparative data or specific details regarding material changes versus prior periods. It only confirms the issuance of results for the period ended June 30, 2025.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the release of a press release regarding Q2 and full-year 2025 results but does not include the text of the commentary, guidance, or outlook.
Risks and Contingencies: No specific risks, contingencies, or unusual items are detailed in this cover document.
Legal Disclaimer: The information in this report and its exhibits is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 15, 2025) for actual revenue, earnings, and cash flow figures.
- Verify the specific details of the "Results of Operations" referenced in Item 2.02.
- Check for any forward-looking statements or updated guidance within the attached press release.
- Confirm the company's status as an emerging growth company and any related accounting election impacts.